Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
59.7M
-
Shares change
-
+536K
-
Total reported value, excl. options
-
$152M
-
Value change
-
-$1.04M
-
Number of buys
-
56
-
Number of sells
-
-41
-
Price
-
$2.54
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q1 2020
109 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q1 2020.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.7M shares
of 374M outstanding shares and own 15.94% of the company stock.
Largest 10 shareholders include Russell Investments Group, Ltd. (7.27M shares), PRIMECAP MANAGEMENT CO/CA/ (6.18M shares), Neuberger Berman Group LLC (5.81M shares), BlackRock Inc. (5.3M shares), Indaba Capital Management, L.P. (3.82M shares), Levin Easterly Partners LLC (3.68M shares), RENAISSANCE TECHNOLOGIES LLC (3.19M shares), Partner Fund Management, L.P. (2.67M shares), ACADIAN ASSET MANAGEMENT LLC (1.54M shares), and PARADIGM CAPITAL MANAGEMENT INC/NY (1.49M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.